Onderzoeker
Bouke de Jong
Affiliaties
- Mycobacteriologie (Onderzoekseenheid)
Lid
Vanaf1 sep 2010 → Heden - Mycobacteriologie (Onderzoekseenheid)
Lid
Vanaf31 aug 2010 → 16 apr 2015
Projecten
1 - 10 of 75
- Can tongue swabs be used to isolate viable Mycobacterium tuberculosis bacilli from PTBVanaf12 dec 2022 → 15 dec 2023
- Omics Data Integratie om antimicrobiële resistentie in Mycobacterium tuberculosis te voorspellenVanaf27 apr 2022 → Heden
- Rwandese instituten tot leiders maken op het gebied van preventie, diagnose en bestrijding van infectieziektenVanaf1 jan 2022 → Heden
- Consolidatie en beheer van het BCCM Consortium als "Belgisch Research Center"Vanaf1 jan 2022 → Heden
- Rapid diagnosis of Mycobacterium tuberculosis resistance, beyond rifampicinVanaf1 jan 2022 → Heden
- TB/NTM OnderzoeksclusterVanaf1 jan 2022 → Heden
- Versterking van de onderzoeks- en onderwijscapaciteit in de partnerinstituten (INRB, CRSK, ESP) in de DRC (OC1) - Ondersteuning van de stopzetting van de overdracht van humane Afrikaanse Trypanosomiasis (HAT) tegen 2030 (OC2)Vanaf1 jan 2022 → Heden
- Multi Omics Data Integration to predict the M. tuberculosis Bedaquiline Resistance Phenotype from the GenotypeVanaf1 jan 2022 → Heden
- Culture-free approaches including whole genome sequencing in support of diagnostic and transmission studies on MycobacteriumVanaf30 jun 2021 → Heden
- Beteugeling van rifampicineresistente tuberculose in Rwanda en daarbuitenVanaf30 jun 2021 → Heden
Publicaties
21 - 30 van 172
- Balancing access to BPaLM regimens and risk of resistance(2022)
Auteurs: A Van Rie, Timothy M. Walker, Bouke de Jong, Rupasinghe Arachchige Praharshinie Rupasinghe, Emmanuel Riviere, S Gagneux, Philip Supply, Viola Dreyer, S Niemann, Galo A Goig, et al.
Pagina's: 1411-1412 - Middlebrook 7h11 reduces invalid results and turnaround time of phenotypic drug‑susceptibility testing of M. tuberculosis(2022)
Auteurs: Rupasinghe Arachchige Praharshinie Rupasinghe, Jens Vereecken, Pieter Graulus, T Decroo, Elisa Ardizzoni, Cathy Hewison, Dimitri Donchuk, Helena Huerga, Anita Mesic, Leen Rigouts, et al.
Pagina's: 407-411 - Multidrug-resistant tuberculosis control in Rwanda overcomes a successful clone that causes most disease over a quarter century(2022)
Auteurs: Jean Claude Semuto Ngabonziza, Leen Rigouts, Gabriela Torrea, T Decroo, Eliane Kamanzi, Pauline Lempens, Aniceth Rucogoza, Yves Mucyo Habimana, Lies Laenen, Esdras Belamo Niyigena, et al.
- Investigating drug resistance of Mycobacterium leprae in the Comoros: an observational deep-sequencing study(2022)
Auteurs: Sofie Braet, Agathe Jouet, Alexandra Aubry, Magalie Van Dyck-Lippens, Esteban Lenoir, Younoussa Assoumani, Abdallah Baco, Aboubacar Mzembaba, Emmanuelle Cambau, Sidra Ezidio Gonçalves Vasconcellos, et al.
Pagina's: e693-e700 - Strain diversity and gene mutations associated with presumptive multidrug-resistant Mycobacterium tuberculosis complex isolates in northwest Ethiopia(2022)
Auteurs: Mebrat Ejo Kitata, Gabriela Torrea, Ermias Diro, Ayenesh Abebe, Meseret Kassa, Yilak Girma, Eyasu Tesfa, Kefialew Ejigu, C Uwizeye, Florian Gehre, et al.
- Acquired rifampicin resistance during first TB treatment: magnitude, relative importance, risk factors and keys to control in low-income settings(2022)
Auteurs: Armand Van Deun, Valentin Bola, Rossin Lebeke, Michel Kayomo Kaswa, Mohamed Anwar Hossain, M Gumusboga, Gabriela Torrea, Bouke de Jong, Leen Rigouts, T Decroo
- High yield of retrospective active case finding for leprosy in Comoros(2022)
Auteurs: Nimer Ortuno-Gutierrez, Aboubacar Mzembaba, Abdallah Baco, Sofie Braet, Assoumani Younoussa, Zahara Salim, Mohamed Amidy, Saverio Grillone, Aouladi Said, Bouke de Jong, et al.
Pagina's: e0010158 - Deep amplicon sequencing for culture-free prediction of susceptibility or resistance to 13 anti-tuberculous drugs(2021)
Auteurs: Agathe Jouet, Cyril Gaudin, Nelly Badalato, Caroline Allix-Béguec, Stéphanie Duthoy, Alice Ferré, Maren Diels, Yannick Laurent, Sandy Contreras, Silke Feuerriegel, et al.
- Thin-layer-agar-based direct phenotypic drug susceptibility testing on sputum in Eswatini rapidly detects Mycobacterium tuberculosis growth and rifampicin resistance otherwise missed by WHO-endorsed diagnostic tests(2021)
Auteurs: Elisa Ardizzoni, E. Ariza, D. Mulengwa, Q. Mpala, R de la Tour, Gugu Maphalala, F. Varaine, Bernhard Kerschberger, Pieter Graulus, A-L Page, et al.
- Second-line injectable drugs for rifampicin-resistant tuberculosis: better the devil we know?(2021)
Auteurs: Sabira Tahseen, Armand Van Deun, Bouke de Jong, T Decroo
Pagina's: 831-835